Glucose Tolerance, Plasma Insulin and Lipids in Diabetic Subjects Before and After Treatment with a New Sulfonylurea Compounds, Ro 6-4563

Overview

Journal Eur J Clin Pharmacol

Specialty Pharmacology

Date 1971 Dec 1

PMID 5151389

Authors

P Berchtold

P Bjorntorp

A Gustafson

A Jonsson

S E FAGERBERG

Affiliations

Soon will be listed here.

References

Johnson B, Bhatia C, Rzeszotarski W, WOLFF F . Preliminary clinical evaluation of glybenclamide in treatment of diabetes mellitus. Diabetes. 1970; 19(8):579-84. DOI: 10.2337/diab.19.8.579. View

KIPNIS D . Insulin secretion in diabetes mellitus. Ann Intern Med. 1968; 69(5):891-901. DOI: 10.7326/0003-4819-69-5-891. View

Feldman J, Lebovitz H . Appraisal of the extrapancreatic actions of sulfonylureas. Arch Intern Med. 1969; 123(3):314-22. View

Berchtold P, Buber V, Meier V, Felber J, KEISER G . [Comparative studies of the oral and intravenous tolbutamide test. II. Determination of glucose, serum-insulin and serum-tolbutamide in normal young subjects]. Diabetologia. 1971; 7(2):77-81. DOI: 10.1007/BF00443885. View

Fredrickson D, Lees R . A SYSTEM FOR PHENOTYPING HYPERLIPOPROTEINEMIA. Circulation. 1965; 31:321-7. DOI: 10.1161/01.cir.31.3.321. View

Anderson J, Coulson R, Grassick B, Morris B, Thomas W, Tomlihson R . Clinical and metabolic study in diabetic patients treated with glibenclamide. Br Med J. 1970; 2(5709):568-70. PMC: 1700241. DOI: 10.1136/bmj.2.5709.568. View

Wajchenberg B, Nakasone K, Pasternak K . Effect of short-term tolbutamide treatment on insulin dynamics in newly diagnosed obese and non-obese adult diabetics. Horm Metab Res. 1970; 2(1):6-8. DOI: 10.1055/s-0028-1095118. View

Phear D . The normal and diabetic patterns of insulin response to glucose. Lancet. 1962; 2(7263):955-8. DOI: 10.1016/s0140-6736(62)90726-2. View

Levin K, Linde S . [Determination of glucose in blood, cerebrospinal fluid and urine with a new glucose oxidase reagent]. Sven Lakartidn. 1962; 59:3016-26. View

10.

CHU P, Conway M, Krouse H, GOODNER C . The pattern of rsponse of plasma insulin and glucose to meals and fasting during chlorpropamide therapy. Ann Intern Med. 1968; 68(4):757-69. DOI: 10.7326/0003-4819-68-4-757. View

11.

Bjorntorp P, Berchtold P, Tibblin G . Insulin secretion in relation to adipose tissue in men. Diabetes. 1971; 20(2):65-70. DOI: 10.2337/diab.20.2.65. View

12.

Appels A, KATTERMANN R, Proschek H, Hubrich K, Frerichs H, SOLING H . [Investigations of the effects of diet, tolbutamide and buformin and their combination on body weight and several metabolic parameters in diabetics. I. Body weight, carbohydrate metabolism and immunoreactive insulin]. Diabetologia. 1968; 4(4):210-20. DOI: 10.1007/BF00430097. View

13.

Reaven G, Dray J . Effect of chlorpropamide on serum glucose and immunoreactive insulin concentrations in patients with maturity-onset diabetes mellitus. Diabetes. 1967; 16(7):487-92. DOI: 10.2337/diab.16.7.487. View

14.

Abramson E, Arky R . Treatment of the obese diabetic. A comparative study of placebo, sulfonylurea and phenformin. Metabolism. 1967; 16(3):204-12. DOI: 10.1016/0026-0495(67)90169-2. View

15.

Morris J, West D, Bolinger R . EFFECT OF ORAL SULFONYLUREA ON PLASMA TRIGLYCERIDES IN DIABETICS. Diabetes. 1964; 13:87-9. DOI: 10.2337/diab.13.1.87. View

16.

Muller W, Faloona G, Unger R . Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion. N Engl J Med. 1970; 283(3):109-15. DOI: 10.1056/NEJM197007162830301. View

17.

Hales C, Randle P . Immunoassay of insulin with insulin antibody preciptate. Lancet. 1963; 1(7274):200. DOI: 10.1016/s0140-6736(63)91215-7. View

18.

Samols E, Tyler J, MIALHE P . Suppression of pancreatic glucagon release by the hypoglycaemic sulphonylureas. Lancet. 1969; 1(7587):174-6. DOI: 10.1016/s0140-6736(69)91189-1. View

19.

Lees R, Hatch F . Sharper separation of lipoprotein species by paper electrophoresis in albumin-containing buffer. J Lab Clin Med. 1963; 61:518-28. View

20.

Sheldon J, Taylor K, Anderson J . The effects of long-term acetohexamide treatment on pancreatic islet cell function in maturity-onset diabetes. Metabolism. 1966; 15(10):874-83. DOI: 10.1016/0026-0495(66)90158-2. View